טוען...

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531

PURPOSE: Infants with stage 4S neuroblastoma usually have favorable outcomes with observation or minimal chemotherapy. However, young infants with symptoms secondary to massive hepatomegaly or with unfavorable tumor biology are at high risk of death. Our aim was to improve outcomes for patients with...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Twist, Clare J., Naranjo, Arlene, Schmidt, Mary Lou, Tenney, Sheena C., Cohn, Susan L., Meany, Holly J., Mattei, Peter, Adkins, E. Stanton, Shimada, Hiroyuki, London, Wendy B., Park, Julie R., Matthay, Katherine K., Maris, John M.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325354/
https://ncbi.nlm.nih.gov/pubmed/30444686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00419
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!